News & ArticlesLatest news and informative articles
Meet us at many events this autumn
Adam de Neergaard talks terminology
All the latest regulatory updates compiled for you by S-cubed.
Elizabeth Merrall fights for statistical truth!
Kirsten Langedorf gets nerdy about graphs!
Latest news from EMA regarding nitrosamines
Johannes Ulander finds himself falling down an SDTM rabbit hole…
Our latest regulatory update focuses on the responsibilities of the Marketing Authorisation Holder.
Our latest Industry Update for Q2 covers the latest regulatory information around COVID-19 and much more.
Dave Iberson-Hurst reflects on a highly successful TransCelerate Hackathon.
How can we drive change in Pharma? It starts with the data.
Our Biometrics team discuss how S-cubed can help companies that outsource Biometrics activities to a full-service CRO.
Latest updates from EMA in response to the COVID-19 pandemic.
The CDISC Interchange has gone virtual and S-cubed will be there in 3 streams.
The deadline for Nitrosamine Risk Evaluation is looming. Are you ready?
Our first Industry Update of 2020 focuses on Clinical Trial Regulation, Brexit and the latest from FDA & EMA.
Clinical monitoring shouldn’t be difficult and in the hands of our expert team, you’ll be set up in no time.
20 years of working with CDISC led to the birth of the A3 Community MDR. Read the story here.
With just one month to go, have you completed your risk evaluations? Make sure you are ready!
What do you know about LOINC? Niels Both gives a personal view of what you need to know.
The EU Pilot for 2 Member States to gain simultaneous national scientific advice is launched on 1st February. Find out more here.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Sign up to receive our newsletters
The industry insights features the latest news and developments from the pharmaceutical industry.
Sign up for our newsletter
Download our latest publication
Featured in this issue of Industry Insights:
- COVID – 19 Guidance During the Pandemic
- Clinical Trial Regulation
- Medical Device Regulation
- Patient Focused Drug Development
If you want to contribute or share something that you’d like to be listed in the next issue, please feel free to contact us.